NCT01272934View on ClinicalTrials.gov

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain

PHASE3CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Acute Ankle Sprain
Interventions
DRUG

Diclofenac Sodium

Topical gel 1%-4 times daily

OTHER

Placebo

Topical gel-4 times daily

Trial Locations (6)

Unknown

NCH investigative site, Bad Nauheim

NCH investigative site, Brühl

NCH investigative site, Cologne

NCH investigative site, Essen

NCH investigative site, Gilching

NCH investigative site, Munich, Germany., Munich

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT01272934 - Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain | Biotech Hunter | Biotech Hunter